Protein kinase Cι is a new prognostic factor in gastric cancer

被引:3
作者
Kashihara, Hideya [1 ]
Shimada, Mitsuo [1 ]
Kurita, Nobuhiro [1 ]
Iwata, Takashi [1 ]
Sato, Hirohiko [1 ]
Yoshikawa, Kozo [1 ]
Miyatani, Tomohiko [1 ]
Takasu, Chie [1 ]
Matsumoto, Noriko [1 ]
机构
[1] Univ Tokushima, Grad Sch, Dept Surg, Inst Hlth Biosci, Tokushima 7708503, Japan
关键词
Protein kinase C iota (PKC iota); Gastric cancer; Vascular endothelial cell growth factor (VEGF); Extracellular signal-regulated kinase (ERK); PKC-IOTA; MUTATIONS; CARCINOMA; ONCOGENE; TUMORS;
D O I
10.1007/s00595-014-1010-5
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purposes Protein kinase C iota (PKC iota) is an important oncogenic K-ras effector, and its expression is correlated with tumor angiogenesis. The role of PKC iota in gastric cancer remains unclear. The aim of this study was to clarify the role of PKC iota in gastric cancer. Methods Twenty-eight patients with gastric cancer who underwent gastrectomy were enrolled in this study. The expression of PKC iota mRNA was determined, as were the clinicopathological factors. The patients were divided into PKC iota high and low expression groups. The 5-year survival rate, ERK mRNA level and VEGF mRNA level were compared between the two groups. The prognostic factors were investigated by a multivariate analysis. Results High expression of PKC iota was observed to be associated with a lack of differentiation, tumor invasion >= muscularis propria <=, stage III and IV disease and peritoneal dissemination. The 5-year survival rate in the PKC iota high group was lower than that in the PKC iota low group. The multivariate analysis revealed that a high expression level of PKC iota was an independent prognostic factor. The expression levels of ERK and VEGF in the PKC iota high group were higher than those in the PKC iota low group. Conclusion Our results indicate that PKC iota is correlated with tumor progression and angiogenesis. PKC iota may be a new prognostic factor for gastric cancer.
引用
收藏
页码:759 / 764
页数:6
相关论文
共 29 条
[1]   Activation of c-K-ras mutations in human gastrointestinal tumors [J].
Arber, N ;
Shapira, I ;
Ratan, J ;
Stern, B ;
Hibshoosh, H ;
Moshkowitz, M ;
Gammon, M ;
Fabian, I ;
Halpern, Z .
GASTROENTEROLOGY, 2000, 118 (06) :1045-1050
[2]   Prognostic Impact of Phosphorylated Mitogen-Activated Protein Kinase Expression in Patients with Metastatic Gastric Cancer [J].
Atmaca, Akin ;
Pauligk, Claudia ;
Steinmetz, Kristina ;
Altmannsberger, Hans-Michael ;
Jaeger, Elke ;
Al-Batran, Salah-Eddin .
ONCOLOGY, 2011, 80 (1-2) :130-134
[3]   Characterization of the CXCR4 signaling in pancreatic cancer cells [J].
Billadeau D.D. ;
Chatterjee S. ;
Bramati P. ;
Sreekumar R. ;
Shah V. ;
Hedin K. ;
Urrutia R. .
Journal of Gastrointestinal Cancer, 2006, 37 (4) :110-119
[4]  
Cooper, 1995, ONCOGENES, P222
[5]   Protein kinase C isozymes and the regulation of diverse cell responses [J].
Dempsey, EC ;
Newton, AC ;
Mochly-Rosen, D ;
Fields, AP ;
Reyland, ME ;
Insel, PA ;
Messing, RO .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2000, 279 (03) :L429-L438
[6]   Atypical PKCι contributes to poor prognosis through loss of apical-basal polarity and Cyclin E overexpression in ovarian cancer [J].
Eder, AM ;
Sui, XM ;
Rosen, DG ;
Nolden, LK ;
Cheng, KW ;
Lahad, JP ;
Kango-Singh, M ;
Lu, KH ;
Warneke, CL ;
Atkinson, EN ;
Bedrosian, I ;
Keyomarsi, K ;
Kuo, WL ;
Gray, JW ;
Yin, JCP ;
Liu, JS ;
Halder, G ;
Mills, GB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (35) :12519-12524
[7]   K-ras mutation in Helicobacter pylori-associated chronic gastritis in patients with and without gastric cancer [J].
Hiyama, T ;
Haruma, K ;
Kitadai, Y ;
Masuda, H ;
Miyamoto, M ;
Tanaka, S ;
Yoshihara, M ;
Shimamoto, F ;
Chayama, K .
INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (05) :562-566
[8]  
Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO
[9]  
2-X
[10]  
Japanese Gastric Cancer Association, 2010, JAP CLASS GASTR CARC